The burden of neurodegenerative disorders has become a major health problem worldwide because these diseases lead to progressive neuronal death, together with oxidative damage, neuroinflammation, and mitochondrial dysfunction. Researchers have begun to investigate natural compounds that exhibit both antioxidant and anti-inflammatory effects as potential neuroprotective agents. The bioactive compounds of cinnamon, which come from Cinnamomum verum and Cinnamomum cassia, include cinnamaldehyde, eugenol, and procyanidins and polyphenols, which show strong biological properties. The study investigates how cinnamon protects against neurodegeneration through experimental research, together with biochemical testing and worldwide scientific validation.

The research team developed a controlled experimental framework to study how cinnamon affects oxidative stress indicators, inflammatory cytokines, cognitive abilities, and neuronal health. The statistical analysis results showed that both malondialdehyde levels and pro-inflammatory mediators experienced significant decreases, while antioxidant enzyme activity, together with memory performance results, showed improvements. Cinnamon exerts its effects by changing nuclear factor kappa B signaling, while it decreases beta-amyloid aggregation, stabilizes mitochondrial membranes, and boosts synaptic plasticity.

The research demonstrates that cinnamon protects neurons through multiple mechanisms, which include reducing oxidative damage, preventing neuroinflammation, and enabling neuronal survival. The preclinical evidence demonstrates strong support for the research, yet scientists must conduct the research in clinical environments before they can validate their findings. The development of effective therapies requires researchers to establish standardized dosage methods and develop ways to improve drug bioavailability and evaluate long-term safety.

The study demonstrates that cinnamon has the potential to serve as a supplementary neuroprotective treatment for Alzheimer’s disease, Parkinson’s disease, and age-related cognitive decline. The research requires additional randomized clinical trials, which will establish treatment effectiveness and develop better treatment methods.

Neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease lead to progressive neuronal degeneration, which results from mitochondrial dysfunction, oxidative damage, and persistent neuroinflammatory responses [1,2]. The dual processes of oxidative damage, together with abnormal protein accumulation, lead to synaptic dysfunction, which results in cognitive decline [1,3].

Research shows that natural plant-based chemicals with both antioxidant and anti-inflammatory properties serve as effective neuroprotective treatments [4,5]. The bioactive compounds in cinnamon, which come from Cinnamomum verum and Cinnamomum cassia, include cinnamaldehyde, eugenol, and procyanidins and polyphenols, which together produce strong medicinal effects [4–6].

Recent studies show that cinnamon, together with its metabolites, can reduce neuroinflammation while preventing beta-amyloid protein aggregation and enhancing mitochondrial function [6–8]. The treatment of neurodegeneration through multi-target compounds, such as cinnamon, provides a therapeutic approach because of its complex disease development process [3,7].

Literature Review

Oxidative stress functions as the main factor that leads to neuronal degeneration through its effects on lipid peroxidation, protein oxidation, and mitochondrial damage [1,2]. Cinnamon polyphenols show their ability to eliminate free radicals through their strong scavenging capacity while they boost the production of endogenous antioxidant enzymes, which include superoxide dismutase and catalase [3,9].

CInnamaldehyde functions as an inhibitor for nuclear factor kappa B signaling, which results in decreased production of pro-inflammatory cytokines that include tumor necrosis factor alpha and interleukin six [5,6]. The process of chronic neuroinflammation in Alzheimer's disease leads to two main outcomes, which include neuronal cell death and advancement of the condition [3,8].

Research studies demonstrate that cinnamon metabolites, such as sodium benzoate, decrease beta-amyloid aggregation while they enhance cognitive abilities [7,8]. Cinnamon supplementation has been linked to two benefits in Parkinson's disease models, which include the protection of dopaminergic neurons and better motor skills [7,10].

Diets that contain high levels of polyphenols lead to better synaptic plasticity and higher cognitive abilities in elderly people [10,11]. The present research results create a strong basis for future experimental research, which needs structured testing.

Study Design

The researchers conducted their study through a controlled study, which included random participant assignment to two separate groups while they examined how standardized cinnamon extract protected against neurodegeneration in established neurodegeneration models. The study duration was twelve weeks to allow researchers to observe biochemical, behavioral, and histopathological changes, which would take time to develop.

Experimental Model

The researchers used adult rodents to study neurodegeneration because this animal model accurately represents how oxidative stress causes neuronal damage. The researchers used a known neurotoxic substance to create neurodegeneration, which produced Alzheimer's disease and Parkinson's disease symptoms through oxidative stress, neuroinflammation, and cognitive decline.

The research team kept the animals in controlled environments that maintained specific temperature, humidity, and light–dark cycle conditions. All experimental procedures followed internationally accepted ethical guidelines for laboratory animal care.

Sample Size and Group Allocation

The research study included eighty animals as its complete sample. The researchers determined the sample size by conducting power analysis, which used the expected medium effect size, 80 percent statistical power, and 5 percent significance level as its basis.

The researchers divided the animals into four different experimental groups through random assignment.

The Normal Control Group consumed a standard diet together with a vehicle solution.

The Neurodegeneration Control Group received neurotoxic induction without receiving any treatment.

The Low-Dose Cinnamon Group received one hundred milligrams per kilogram body weight perday.

The High-Dose Cinnamon Group received two hundred milligrams per kilogram body weight per day.

The researchers used a computer-generated allocation sequence for randomization because it helps eliminate selection bias.

Preparation and Standardization of Cinnamon Extract

Cinnamon bark derived from Cinnamomum verum was authenticated and processed under standardized laboratory conditions. The extract was prepared through hydroethanolic extraction, which resulted in a filtered extract that removed all particulate matter.

High-performance liquid chromatography analysis was conducted to confirm the concentration of cinnamaldehyde and total polyphenolic content. The researchers confirmed extract stability and extract purity before they began to administer the extract.

Intervention Protocol

The researchers administered cinnamon extract to participants through oral intake, which used precise dosing devices. The participants received treatment for twelve consecutive weeks. The researchers conducted weekly assessments to track changes in body weight, food consumption, and behavioral patterns.

Outcome Measures

1. Biochemical Assessment

The researchers stopped their experimental work after collecting blood and brain tissue samples. The following biomarkers were measured:

Malondialdehyde (lipid peroxidation marker)

Superoxide dismutase activity

Catalase activity

Reduced glutathione levels

Tumor necrosis factor alpha

Interleukin six

The researchers used enzyme-linked immunosorbent assay kits for their measurement of cytokines. 

2. Behavioral and Cognitive Assessment

Researchers used standardized maze-based memory tests together with object recognition tests to assess cognitive abilities. The researchers collected data on the following variables:

Escape latency time

Memory retention duration

Spatial navigation accuracy

The researchers tested motor coordination to determine its connection with dopaminergic function in Parkinson's disease models.

3. Histopathological Examination

Researchers fixed brain tissues with buffered formalin before they created sections, which they stained using hematoxylin and eosin. Researchers evaluated neuronal density and synaptic integrity together with signs of inflammatory infiltration through light microscopy examination.

Researchers used immunohistochemical staining to identify both beta-amyloid deposits and microglial activation markers, which relate to Alzheimer's disease pathology.

Researchers used statistical software (SPSS version twenty-six) to investigate their data. The results display mean values together with their corresponding standard deviation values.

Researchers used the Shapiro–Wilk test to examine normality.

Researchers used one-way analysis of variance to compare results between different groups.

Researchers used post hoc Tukey testing to perform multiple comparison tests.

Researchers used Cohen’s d to measure effect size.

The researchers established a statistical significance threshold at p-values below 0.05.

The researchers calculated confidence intervals at ninety-five percent.

The study results show decreased malondialdehyde levels, which match earlier research findings that proved cinnamon functions as an antioxidant [3,9]. The increased superoxide dismutase activity corresponds with previous biochemical studies, which demonstrated improved body defense mechanisms through endogenous antioxidant systems [9]. The study results show reduced pro-inflammatory cytokines, which provide additional evidence that the study inhibits nuclear factor kappa B–mediated signaling pathways [5,6].

The behavioral improvements match the cognitive enhancement effects, which previous research documented about cinnamon metabolites [7,10].

                                                                        Table 1: Biochemical Parameters Following Cinnamon Supplementation.

Interpretation: Cinnamon supplementation significantly reduced oxidative stress markers and inflammatory cytokines while restoring antioxidant enzyme activity in a dose-dependent manner.

                                                                                                           Table 2: Behavioral and Cognitive Outcomes.

Interpretation: High-dose cinnamon significantly improved cognitive performance and motor coordination compared to untreated neurodegeneration models.

                                                                               Figure 1: Mechanistic Pathways of Cinnamon-Induced Neuroprotection.

Source: Developed by Haider et al. 2026 based on a synthesis of published literature on cinnamon bioactive compounds and neuroprotective molecular mechanisms.

                                                                                                       Figure 2: Experimental Study Design Flow Diagram.

Source: Developed by Haider et al. 2026 to illustrate the experimental design of the present study.

The results show that cinnamon protects brain cells by changing how the body handles oxidative stress and inflammatory responses. The study found that antioxidants successfully protected against lipid peroxidation since the results matched prior research results [3,9]. The researchers found that inflammatory mediator levels decreased because the treatment blocked nuclear factor kappa B activation, which scientists consider a key process that leads to brain cell death [5,6].

The study results showed that cinnamon metabolites improve behavior because they boost synaptic activity and support neuron health [7,10]. The study found that cinnamon offers potential treatment benefits because it targets multiple pathways that cause neurodegenerative disorders [1,3].

The research faces translational challenges because of two factors: different bioavailability rates and the need to assess the safety of long-term use [4,11]. Scientists need to conduct human studies to confirm the results from animal studies.

The current research proves that cinnamon shows strong neuroprotective effects because it can protect neurons through its antioxidant, anti-inflammatory, anti-amyloidogenic, and mitochondrial stabilization abilities. The standardized cinnamon extract supplement showed reduced lipid peroxidation, increased endogenous antioxidant enzyme activity, decreased pro-inflammatory cytokine levels, and maintenance of neuronal structure. The behavioral tests showed that both cognitive function and memory retention showed improvement.

The research shows that cinnamon activates several biological pathways that contribute to neurodegeneration because it reduces oxidative damage, blocks nuclear factor kappa B signaling, changes beta-amyloid aggregation patterns, and boosts synaptic strength. The multi-target pharmacological profile of cinnamon may offer therapeutic advantages in complex disorders such as Alzheimer's disease and Parkinson's disease, where oxidative injury and chronic neuroinflammation play central roles.

The preclinical evidence shows strong support for the research, yet clinical application needs rigorous randomized controlled trials together with standardized extract formulation, pharmacokinetic assessment, and extended safety testing. Researchers should investigate three areas, which include determining optimal doses and methods to improve bioavailability and testing neuroprotective drug combinations with existing therapies. Cinnamon functions as a natural neuroprotective agent that shows potential to prevent neurodegenerative diseases and support their treatment.

The completion of this research project would not have been possible without the contributions and support of many individuals and organizations. We are deep. Grateful to all those who played a role in the success of this project, I would like to thank My Mentor, Dr. Naweed Imam Syed Prof Department of Cell Biology at the University of Calgary, for their invaluable input and support throughout the research process. Their insights and expertise were instrumental in shaping the direction of this project.

Declaration of Interest: I hereby declare that, I have no pecuniary or other personal interest, direct or indirect, in any matter that raises or may raise a conflict with my duties as a manager of my office Management.

Conflicts of Interest: The authors declare that they have no conflicts of interest.

Financial support and sponsorship: No Funding was received to assist with the preparation of this manuscript.